每經AI快訊(xun)，康華生物（SZ 300841，收(shou)盤價：99.29元）7月(yue)18日(ri)(ri)晚間發布公(gong)(gong)(gong)告(gao)(gao)(gao)稱(cheng)，直接(jie)持(chi)(chi)有(you)成都(dou)康華生物制品股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)(yue)19萬股(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)本(ben)(ben)(ben)剔除回(hui)(hui)購專用(yong)賬(zhang)(zhang)(zhang)戶股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)后(hou)(hou)的(de)(de)(de)比(bi)例(li)為(wei)(wei)(wei)0.1391%）的(de)(de)(de)董事、高(gao)級管理人(ren)員(yuan)侯文禮先生，計劃(hua)(hua)自(zi)本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起15個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以集中(zhong)競價方(fang)(fang)(fang)式減(jian)(jian)持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不超過(guo)(guo)約(yue)(yue)1.34萬股(gu)(gu)(gu)(gu)。直接(jie)持(chi)(chi)有(you)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)(yue)28.8萬股(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)本(ben)(ben)(ben)剔除回(hui)(hui)購專用(yong)賬(zhang)(zhang)(zhang)戶股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)后(hou)(hou)的(de)(de)(de)比(bi)例(li)為(wei)(wei)(wei)0.2152%）的(de)(de)(de)高(gao)級管理人(ren)員(yuan)陳(chen)懷恭先生，計劃(hua)(hua)自(zi)本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起15個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以集中(zhong)競價方(fang)(fang)(fang)式和(he)/或本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起3個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以大(da)宗(zong)(zong)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)方(fang)(fang)(fang)式減(jian)(jian)持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)合計不超過(guo)(guo)約(yue)(yue)7.2萬股(gu)(gu)(gu)(gu)。直接(jie)持(chi)(chi)有(you)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)(yue)18.61萬股(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)本(ben)(ben)(ben)剔除回(hui)(hui)購專用(yong)賬(zhang)(zhang)(zhang)戶股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)后(hou)(hou)的(de)(de)(de)比(bi)例(li)為(wei)(wei)(wei)0.1391%）的(de)(de)(de)高(gao)級管理人(ren)員(yuan)孫(sun)晚豐(feng)先生，計劃(hua)(hua)自(zi)本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起15個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以集中(zhong)競價方(fang)(fang)(fang)式減(jian)(jian)持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不超過(guo)(guo)約(yue)(yue)1.33萬股(gu)(gu)(gu)(gu)。合計直接(jie)持(chi)(chi)有(you)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)(yue)84.1萬股(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)本(ben)(ben)(ben)剔除回(hui)(hui)購專用(yong)賬(zhang)(zhang)(zhang)戶股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)后(hou)(hou)的(de)(de)(de)比(bi)例(li)為(wei)(wei)(wei)0.6284%）的(de)(de)(de)股(gu)(gu)(gu)(gu)東(dong)(dong)吳明、趙(zhao)波、曾偉、劉瑾(jin)、馬樹紅、張(zhang)亮、孫(sun)立春、王富、馮勇、楊(yang)剛強(qiang)、黃(huang)貴娟、趙(zhao)志(zhi)鵬、王基宏、張(zhang)濤，計劃(hua)(hua)自(zi)本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起3個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以集中(zhong)競價方(fang)(fang)(fang)式減(jian)(jian)持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不超過(guo)(guo)約(yue)(yue)15.53萬股(gu)(gu)(gu)(gu)；直接(jie)持(chi)(chi)有(you)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約(yue)(yue)19.32萬股(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)本(ben)(ben)(ben)剔除回(hui)(hui)購專用(yong)賬(zhang)(zhang)(zhang)戶股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)后(hou)(hou)的(de)(de)(de)比(bi)例(li)為(wei)(wei)(wei)0.1444%）的(de)(de)(de)股(gu)(gu)(gu)(gu)東(dong)(dong)黎煒計劃(hua)(hua)自(zi)本(ben)(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)(gao)披露(lu)之(zhi)日(ri)(ri)起3個(ge)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)日(ri)(ri)后(hou)(hou)的(de)(de)(de)6個(ge)月(yue)內(nei)(nei)以集中(zhong)競價方(fang)(fang)(fang)式和(he)大(da)宗(zong)(zong)交(jiao)(jiao)(jiao)易(yi)(yi)(yi)方(fang)(fang)(fang)式減(jian)(jian)持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不超過(guo)(guo)約(yue)(yue)4.31萬股(gu)(gu)(gu)(gu)。

2021年1至12月份，康華生(sheng)物的營業收入構成為：非免疫規劃疫苗占(zhan)比(bi)99.99%，其(qi)他占(zhan)比(bi)0.01%。

康華生物的董事(shi)長是王(wang)振滔，男(nan)(nan)，57歲，學歷(li)(li)背景為(wei)碩士(shi)；總經理是王(wang)清瀚，男(nan)(nan)，49歲，學歷(li)(li)背景為(wei)碩士(shi)。

截至(zhi)發(fa)稿，康華生物市(shi)值(zhi)為134億元。

道(dao)達(da)號（daoda1997）“個(ge)股趨勢”提醒：
1. 康華生物近30日內北向資金持股量增加51.74萬股，占流通股比例增加0.57%；
2. 近30日內共有1批機構對康華生物調研，合計調研的機構家數為3家；
3. 康華生物上次發布減持公告是2022年07月13日，第二個交易日上漲4.51%，康華生物近一年共發布25次減持類公告。
更多個股趨勢信(xin)息(xi)，請搜索微(wei)信(xin)公眾(zhong)號“道達號”，回復“查詢”，領取(qu)免費查詢權(quan)限(xian)！

每經頭條（nbdtoutiao）——

(記者 曾健輝)

免(mian)責聲(sheng)明：本(ben)文內容與數據僅供參考，不構成投資建(jian)議(yi)，使用前(qian)請(qing)核實。據此操作，風險自(zi)擔。